HUP0002154A3 - Use of famotidine for the preparation of pharmaceutical compositions treating depression or symptoms related with depression - Google Patents

Use of famotidine for the preparation of pharmaceutical compositions treating depression or symptoms related with depression

Info

Publication number
HUP0002154A3
HUP0002154A3 HU0002154A HUP0002154A HUP0002154A3 HU P0002154 A3 HUP0002154 A3 HU P0002154A3 HU 0002154 A HU0002154 A HU 0002154A HU P0002154 A HUP0002154 A HU P0002154A HU P0002154 A3 HUP0002154 A3 HU P0002154A3
Authority
HU
Hungary
Prior art keywords
depression
famotidine
preparation
pharmaceutical compositions
symptoms related
Prior art date
Application number
HU0002154A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Priority to HU0002154A priority Critical patent/HUP0002154A3/hu
Publication of HU0002154D0 publication Critical patent/HU0002154D0/hu
Priority to AU2001266242A priority patent/AU2001266242A1/en
Priority to DE60112750T priority patent/DE60112750T2/de
Priority to PCT/HU2001/000065 priority patent/WO2001093863A2/en
Priority to JP2002501436A priority patent/JP2003535133A/ja
Priority to EP01943711A priority patent/EP1289520B1/en
Priority to DK01943711T priority patent/DK1289520T3/da
Priority to AT01943711T priority patent/ATE302000T1/de
Priority to US10/297,280 priority patent/US20040010021A1/en
Priority to ES01943711T priority patent/ES2247137T3/es
Publication of HUP0002154A2 publication Critical patent/HUP0002154A2/hu
Publication of HUP0002154A3 publication Critical patent/HUP0002154A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
HU0002154A 2000-06-06 2000-06-06 Use of famotidine for the preparation of pharmaceutical compositions treating depression or symptoms related with depression HUP0002154A3 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
HU0002154A HUP0002154A3 (en) 2000-06-06 2000-06-06 Use of famotidine for the preparation of pharmaceutical compositions treating depression or symptoms related with depression
ES01943711T ES2247137T3 (es) 2000-06-06 2001-06-06 Composiciones farmaceuticas para el tratamiento de la depresion que contienen famotidina.
JP2002501436A JP2003535133A (ja) 2000-06-06 2001-06-06 うつ病またはうつ様症状の治療のための医薬組成物
DE60112750T DE60112750T2 (de) 2000-06-06 2001-06-06 Pharmazeutische zusammensetzung enthaltend famotidine für die behandlung von depressionen
PCT/HU2001/000065 WO2001093863A2 (en) 2000-06-06 2001-06-06 Pharmaceutical compositions for the treatment of depression or symptoms suggesting depression
AU2001266242A AU2001266242A1 (en) 2000-06-06 2001-06-06 Pharmaceutical compositions for the treatment of depression or symptoms suggesting depression
EP01943711A EP1289520B1 (en) 2000-06-06 2001-06-06 Pharmaceutical compositions for the treatment of depression comprising famotidine
DK01943711T DK1289520T3 (da) 2000-06-06 2001-06-06 Farmaceutiske præparater indeholdende famotidin til behandling af depression
AT01943711T ATE302000T1 (de) 2000-06-06 2001-06-06 Pharmazeutische zusammensetzung enthaltend famotidine für die behandlung von depressionen
US10/297,280 US20040010021A1 (en) 2000-06-06 2001-06-06 Pharmaceutical compositions for the treatment of depression or symptoms suggesting depression

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0002154A HUP0002154A3 (en) 2000-06-06 2000-06-06 Use of famotidine for the preparation of pharmaceutical compositions treating depression or symptoms related with depression

Publications (3)

Publication Number Publication Date
HU0002154D0 HU0002154D0 (en) 2000-08-28
HUP0002154A2 HUP0002154A2 (hu) 2002-04-29
HUP0002154A3 true HUP0002154A3 (en) 2002-06-28

Family

ID=89978380

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0002154A HUP0002154A3 (en) 2000-06-06 2000-06-06 Use of famotidine for the preparation of pharmaceutical compositions treating depression or symptoms related with depression

Country Status (10)

Country Link
US (1) US20040010021A1 (enExample)
EP (1) EP1289520B1 (enExample)
JP (1) JP2003535133A (enExample)
AT (1) ATE302000T1 (enExample)
AU (1) AU2001266242A1 (enExample)
DE (1) DE60112750T2 (enExample)
DK (1) DK1289520T3 (enExample)
ES (1) ES2247137T3 (enExample)
HU (1) HUP0002154A3 (enExample)
WO (1) WO2001093863A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8058296B2 (en) * 2008-11-25 2011-11-15 Richard Tokunaga Treatment and prevention of deleterious effects associated with alcohol consumption
US20150329540A1 (en) 2012-12-28 2015-11-19 Shin Nippon Biomedical Laboratories, Ltd. Oct3 activity inhibitor containing imidazopyridine derivative as active component, and oct3 detection agent
EP3018125B1 (en) 2013-07-03 2020-08-05 Shin Nippon Biomedical Laboratories, Ltd. Novel compound, organic cation transporter 3 detection agent, and organic cation transporter 3 activity inhibitor
WO2015163832A1 (en) 2014-04-25 2015-10-29 Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A.Ş. An ibuprofen and famotidine combined composition having improved stability
IL311338A (en) * 2024-03-07 2025-10-01 Ariel Scient Innovations Ltd Using hyaluronic acid to treat mental disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5460825A (en) * 1990-05-23 1995-10-24 Mcneil-Ppc, Inc. Taste mask coatings for preparing chewable pharmaceutical tablets
US5352688A (en) * 1991-02-14 1994-10-04 The Mount Sinai School Of Medicine Of The City University Of New York Methods for the treatment of bradyphrenia in parkinson's disease
AU7322394A (en) * 1993-07-06 1995-02-06 Mcneil-Ppc, Inc. H2 antagonist-sucralfate-antiflatulent combinations
AU7218294A (en) * 1993-07-06 1995-02-06 Mcneil-Ppc, Inc. H2 antagonist-alginate combinations

Also Published As

Publication number Publication date
ES2247137T3 (es) 2006-03-01
DE60112750D1 (de) 2005-09-22
EP1289520B1 (en) 2005-08-17
AU2001266242A1 (en) 2001-12-17
DK1289520T3 (da) 2005-10-17
EP1289520A2 (en) 2003-03-12
DE60112750T2 (de) 2006-06-08
HUP0002154A2 (hu) 2002-04-29
WO2001093863A2 (en) 2001-12-13
WO2001093863A3 (en) 2002-05-02
JP2003535133A (ja) 2003-11-25
HU0002154D0 (en) 2000-08-28
US20040010021A1 (en) 2004-01-15
ATE302000T1 (de) 2005-09-15

Similar Documents

Publication Publication Date Title
PT1181027E (pt) Composicao dietetica ou farmaceutica para utilizacao na prevencao ou tratamento de hiperoxaluria
PT1757606E (pt) Utilização de derivados de xantina como produto farmacêutico, bem como seu processo de preparação
HUP0101158A3 (en) Use of glycogen phosphorylase inhibitors for the preparation of pharmaceutical compositions for the prophylactic treatment of type 2 diabetes mellitus
IL196301A0 (en) Medicament for the treatment of hapatitis c
IL155196A0 (en) Benzamide derivatives and pharmaceutical compositions containing the same
HUP0102039A3 (en) Use of paclitaxel stabilized with albumin for the preparation of pharmaceutical compositions treating solid tumors and the pharmaceutical compositions obtained thereby
HUP0401642A3 (en) Use of staurosporine derivatives for the preparation of pharmaceutical compositions
HUP0401514A3 (en) Pharmaceutical compositions for the treatment of asthma
IL203923A (en) Benzamide compounds, pharmaceutical compositions comprising them, use thereof in the preparation of medicaments and as medicaments and processes for the preparation of such compounds
IL158076A0 (en) Benzamidine derivatives and pharmaceutical compositions containing the same
HUP0301325A3 (en) Stabilized pharmaceutically effective composition and pharmaceutical composition comprising the same and process for preparation the composition
HUP0004120A3 (en) Use of cgmp-pde5 inhibitors for the preparation of pharmaceutical compositions treating neuropathy
IL161616A0 (en) Indazolypyrrolotriazine derivatives and pharmaceutical compositions containing the same
IL152451A0 (en) 2-chloro-2-nitrophenylcarboxamide derivatives and pharmaceutical compositions containing the same
GB2361186B (en) Formulation for the prevention of cardiovascular disease
IL158044A0 (en) Cyclopropylindole derivatives and pharmaceutical compositions containing the same
IL158300A0 (en) Bisarylimidazol derivatives and pharmaceutical compositions containing the same
HRP20030046A2 (en) Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome
EE05020B1 (et) Glburiidi ravimkoostis
IL156812A0 (en) Phthalazinone-piperidino derivatives and pharmaceutical compositions containing the same
HUP0202233A3 (en) Derivatives and analogues of galanthamin, their use, pharmaceutical compositions containing them and process for the preparation of them
GB0108470D0 (en) Pharmaceutical compositions and their use
IL159006A0 (en) Phenoxy-phenyl derivatives and pharmaceutical compositions containing the same
HUP0303731A3 (en) Sulfonylguanidines and their use for preparation of pharmaceutical compositions
HUP0102159A3 (en) Pharmaceutical composition for the treatment of rumen acidosis

Legal Events

Date Code Title Description
HC9A Change of name, address

Owner name: RICHTER GEDEON NYRT., HU

Free format text: FORMER OWNER(S): RICHTER GEDEON VEGYESZETI GYAR RT., HU

FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished